The vaccines of the future against infections such as influenza and cancer can be administered using an electrical pulse and a specially-produced DNA code from the University of Oslo (UiO). The DNA code programs the body’s own cells to produce a super-fast defence against the disease. Researchers have developed a new type of DNA vaccine that can be used effectively against viruses and cancer. Studies reveal that the new vaccine triggers a powerful immune response. The vaccine has been tested on mice. Now the researchers hope the vaccine can be tested clinically. This vaccine has an additional advantage. At the moment, vaccines require the inclusion of immuno-activating substances. These substances are called adjuvants and are generally comprised of oil-based mixtures or aluminium salts. Adjuvants initiate local and often painful inflammation at the injection site. This inflammation fools the immune system into reacting to the vaccine. Without additives The new vaccine from UiO does not...
🔒 Premium Content - For Free
Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!




